Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Triana Biomedicines has raised $120.0M in total funding. The most recent round was Series B. The last funding was announced in December 2025.
Triana Biomedicines's investors include Lightspeed Venture Partners, RA Capital Management, Bessemer Venture Partners, Invus, Ascenta Capital.
Triana Biomedicines is headquartered in Lexington, United States.
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Triana Biomedicines is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Triana Biomedicines — Funding & Investors." VCBacked, December 3, 2025, https://www.vcbacked.co/company/triana-biomedicines. Accessed August 14, 2026.
VCBacked. (2025). Triana Biomedicines — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/triana-biomedicines
{{cite web |title=Triana Biomedicines — Funding & Investors |url=https://www.vcbacked.co/company/triana-biomedicines |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated